Dual allosteric effect in glycine/NMDA receptor antagonism: A comparative QSAR approach

Pharmaceuticals

Volumn 3, Issue 10, 2010, Pages 3167-3185

  Sharma, Manish ^a,b   Gupta, Vipin B ^a  

^a B R NAHATA COLLEGE OF PHARMACY   (India)

^b Jodhpur National University   (India)

Author keywords

Allosterism; CMR; Comparative QSAR; Glycine NMDA; Quinoxalines

Indexed keywords

2 CARBOXYTETRAHYDROQUINOLINE DERIVATIVE; 3 NITRO 3,4 DIHYDRO 2(1H) QUINOLONE DERIVATIVE; 3 PHENYL 4 HYDROXY 2 QUINOLONE DERIVATIVE; 3 PHENYLQUINOLIN 2(1H) ONE DERIVATIVE; 4 AMIDO 2 CARBOXYTETRAHYDROQUINOLINE DERIVATIVE; 4 HYDROXYQUINOLIN 2(1H) ONE DERIVATIVE; GLYCINE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITROQUINOLONE DERIVATIVE; PHENYLHYDROXYQUINOLONE DERIVATIVE; QUINAZOLINE 2 CARBOXYLIC ACID DERIVATIVE; QUINOXALIN 4 ONE DERIVATIVE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CHEMOMETRICS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

EID: 78650089226     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3103167     Document Type: Article

References (42)

1. Choi, D.W. Calcium; still center-stage in hypoxic-ischemic neuronal death, TINS 1995, 18, 58-60.
2. Rothman, S.M.; Onley, J.W. Excitatoxicity and the NMDA receptor-still lethal after eight years. TINS 1995, 18, 57-58.
3. Bridges, R.J.; Stevens, D.R.; Kahle, J.S.; Nunn, P.B.; Kadri, M.; Cotman, C.W. Structure- function studies on N-oxalyl-diamino-dicarboxylic acids excitatory amino acids receptor; evidence that beta-L-ODAP is a selective non-NMDA agonist. J. Neurosci. 1989, 9, 2073-2079.
4. Meldrum, B.S. Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathol. 1993, 3, 405-412.
5. Westerberg, E.; Monaghan, D.T.; Cotman, C.W.; Wieloch, T. Excitatory amino acids receptors and ischemic brain damage in the rat. Neurosci. Lett. 1987, 73, 119-124.
6. Wieloch, T. Hypoglycemia- induced neuronal damage prevented by an N-methyl-D-aspartate antagonists. Science 1985, 230, 681-683.
7. Leeson, P.D.; Iversen, L.L. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J. Med. Chem. 1994, 37, 4053-4067.
8. McBain, C.J.; Mayer M.L. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 1994, 74, 723-760.
9. Moriyoshi, K.; Masu, M.; Ishii, T.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. Molecular cloning and characterization of the rat NMDA receptor. Nature 1991, 354, 31-37.
10. Hollmann, M.; Heinemann, S. Cloned glutamate receptors. Annu. Rev. Neurosci. 1994, 17, 31-108.
11. Das, S.; Sasaki, Y.F.; Rothe, T.; Premkumar, L.S.; Takasu, M.; Crandall, J.E.; Dikkes, P.; Conner, D.A.; Rayudu, P.V.; Cheung, W.; Chen, H.S.V.; Lipton, S.A.; Nakanishi, N. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 1998, 393, 377-381.
12. Nishi, M.; Hinds, H.; Lu, H.P.; Kawata, M.; Hayashi, Y. Motoneuron-specific expression of nr3b, a novel nmda-type glutamate receptor subunit that works in a dominant-negative manner. J. Neurosci. 2001, 21, 1-6.
13. Chatterton, J.E.; Awobuluyi, M.; Premkumar, L.S.; Takahashi, H.; Talantova, M.; Shin, Y.; Cui, J.; Tu, S.; Sevarino, K.A.; Nakanishi, N.; Tong, G.; Lipton, S.A.; Zhang, D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 2002, 415, 793-798.
14. Jansen, M.; Dannhardt, G. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions. Eur. J. Med. Chem. 2003, 38, 661-670.
15. Hansch, C.; Hoekman, D.; Gao, H. Comparative QSAR: toward a deeper understanding of chemicobiological interactions. Chem. Rev. 1996, 96, 1045-1075.
16. Crum-Brown, A.; Fraser, T. On the connection between chemical constitution and physiological action. Part 1. On the physiological action of the ammonium bases, derived from Strychia, Brucia, Thebaia, Codeia, Morphia and Nicotia. Trans. R. Soc. Edinburgh 1868, 25, 151-203.
17. Verloop, A. QSAR and Strategies in the Design of Bioactive Compounds. In Proceedings of the 5th European Symposium on QSAR; Seydel, J.K., Ed.; VCH: Weinheem, Germany, 1985; pp. 98-104.
18. Hansch, C.; Garg, R.; Kurup A. Searching for allosteric via QSARs. Bioorg. Med. Chem. 2001, 9, 283-289.
19. Monod, J.; Changeux, J.P; Jacob, F. Allosteric proteins and cellular control systems. J. Mol. Biol. 1963, 6, 306-329.
20. Selassie, C.D.; Klein, T.E. In Comparative QSAR; Devillers, J., Ed.; Taylor and Francis: New York, 1998; pp. 235-284.
21. Cramer III, R.D.; Bunce, J.D.; Patterson, D. E.; Frank, I.E. Crossvalidation, bootstrapping, and partial least squares. compared with multiple regression in conventional. QSAR studies. Quant. Struct. Act. Relat. 1988, 7, 18-25.
22. Verma, R.P.; Hansch, C. Taxane analogues against breast cancer: a quantitative structure-activity relationship study. Chem. Med. Chem. 2008, 3, 642-652.
23. Jaworska, J.; Nikolova-Jeliazkova, N.; Aidenberg, T. QSAR applicability domain estimation by projection of the training set in descriptor space: a review. ATLA 2005, 33, 445-459.
24. Rowley, M.; Leeson, P.D.; Stevenson, G.I.; Mosley, A.M.; Stansfield, I.; Sanderson, I.; Robinson, L.; Baker, R.; Kemp, J.A.; Marshall, G.R.; Foster, A.C.; Grimwood, S.; Tricklebank, M.D.; Saywell, K.L. 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-Methyl-D-Aspartate receptor complex. J. Med. Chem. 1993, 36, 3386-3396.
25. Leeson, P.D.; Carling, R.W.; Moore, K.W.; Moseley, A.M.; Smith, J.D.; Stevenson, T.C.; Baker, R.; Foster, A.C.; Grimwood, S.; Kemp, J.A.; Marshall, G.R.; Hoogsteen, K. 4-Amido-2carboxytetrahydroquinolines. structure-activity relationships for antagonism at the glycine site of the NMDA receptor. J. Med. Chem. 1992, 35, 1954-1968.
26. Kulagowski, J.J.; Baker, R.; Curtis, N.R.; Leeson, P.D.; Mawer, I.M.; Moseley, A.M.; Ridgill, M.P.; Rowley, M.; Stansfield, I.; Foster, A.C.; Grimwood, S.; Hill, R.G.; Saywell, K.L.; Tricklebank, M.D. 3′-(arylmethyl)- and 3′-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor. J. Med. Chem. 1994, 37, 1402-1405.
27. Carling, R.W.; Leeson, P.D.; Moore, K.; Smith, J.D.; Moyes, C.R.; Mawer, I.M.; Thomas, S.; Chan, T.; Baker,; Foster, A.C.; Grimwood, S.; Kemp, J.A.; Marshall, G.R.; Tricklebank, M.D.; Saywell, K.L. 3-nitro-3,4-dihydro-2(1H)-quinolones. excitatory amino acid antagonists acting at glycine-site NMDA and (RS)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. J. Med. Chem. 1993, 36, 3397-3408.
28. Carling, R.W.; Leeson, P.D.; Moore, K.; Smith J.D.; Moyes, C.R.; Dunction, M.; Hudson, M.L.; Baker, R.; Foster, A.C.; Grimwood, S.; Kemp, J.A.; Marshall, G.R.; Tricklebank, M.D.; Saywell, K.L. 4-substituted-3-phenylquinolin-2(1h)-ones: acidic and nonacidic glycine site n-methyl-d-aspartate antagonists with in vivo activity. J. Med. Chem. 1997, 40, 754-765.
29. McQuaid, L.A.; Smith, E.C.R.; Lodge, D.; Pralong, E.; Wikel, J.H.; Calligaro, D.O.; O'Malley, P.J. 3-phenyl-4-hydroxyquinoline- 2(1h)-ones: potent and selective antagonists at the strychnine-insensitive glycine site on the n-methyl-d-aspartate receptor complex. J. Med. Chem. 1992, 35, 3423-3425.
30. Fabio, R.D.; Capelli, A.M.; Conti, N.; Cugola, A.; Donati, D.; Feriani, A.; Gastaldi, P.; Gaviraghi, G.; Hewkin, C.T.; Micheli, F.; Missio, A.; Mugnaini, M.; Pecunioso, A.; Quaglia, A.M.; Ratti, E.; Rossi, L.; Tedesco, G.; Trist, D.G. Reggiani, A. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. J. Med. Chem. 1997, 40, 841-850.
31. Garg, R.; Kurup, A.; Mekapati, S.B.; Hansch, C. Searching for allosteric effects via QSAR. part ii. Bioorg. Med. Chem. 2003, 11, 621-628.
32. Baron, B.M.; Cregge, R.J.; Farr, R.A.; Friedrich, D.; Gross, R.S.; Harrison, B.L.; Janowick, D.A.; Matthews, D.; McCloskey, T.C.; Meikrantz, S.; Nyce, P.L.; Vaz, R.; Metz, W.A. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist. J. Med. Chem. 2005, 48, 995-1018.
33. Baskin, I.I.; Tikhonova, I.G.; Palyulin, V.A.; Zefirov, N.S. Selectivity fields: comparative molecular field analysis (CoMFA) of the Glycine/NMDA and AMPA receptors. J. Med. Chem. 2003, 46, 4063-4069.
34. Tikhonova, I.G.; Baskin, I. I.; Palyulin, V. A; Zefirov, N. S. CoMFA and homology-based models of the glycine binding site of N-methyl-D-aspartate receptor. J. Med. Chem. 2003, 46, 1609-1616.
35. Bacilieri M.; Varano F.; Deflorian F.; Marini M.; Catarzi D.; Colotta V.; Filacchioni G.; Galli A.; Costagli C.; Kaseda C.; Moro S. Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: design of new Gly/NMDA receptor antagonists as a key study. J. Chem. Inf. Model. 2007, 47, 1913-1922.
36. Patankar, S.J.; Jurs P.C. Prediction of glycine/NMDA receptor antagonist inhibition from molecular structure. J. Chem. Inf. Comput. Sci. 2002, 42, 1053-1068.
37. Bender, W.; Staudt, M.; Trankle, C.; Mohr, K. Probing the size of a hydrophobic binding pocket within the allosteric site of muscarinic acetylcholine M2-receptors. Life Sci. 2000, 66, 1675-1682.
38. Hansch, C.; Garg, R.; Kurup, A. Searching for allosteric effects via QSARS. Bioorg. Med. Chem. 2001, 9, 283-289.
39. Monod, J.; Wyman, J.; Changeux, J.-P. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 1965, 12, 88-118.
40. Changeux, J.P.; Edelstein, S.J. Allosteric Receptors after 30 Years. Neuron, 1998, 21, 959-980.
41. Koshland, D.E., Jr. Application of a theory of enzyme specificity to protein synthesis. Proc. Natl. Acad. Sci. USA 1958, 44, 98-104.
42. Christopoulos, A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nature Rev. Drug Dis. 2002, 1, 198-210.